Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

The type 5 metabotropic glutamate receptor, mGlu5, has been proposed as a potential therapeutic target for the treatment of several neurodegenerative diseases. In preclinical neurodegenerative disease models, novel allosteric modulators have been shown to improve cognitive performance and reduce dis...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rebecca F. Budgett, Geor Bakker, Eugenia Sergeev, Kirstie A. Bennett, Sophie J. Bradley
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2022-05-01
Collection:Frontiers in Pharmacology
Sujets:
GPCR
Alzheimer’s disease
neurodegenerative disease
neuroinflammation
G protein coupled receptors
drug discovery
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fphar.2022.893422/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires